Ji-Feng Feng (Jifeng Feng, Feng Jifeng)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 29

Top Topics

Small Cell Lung Cancer

Liver Metastases

Signaling Pathway

Top Venues

Thoracic cancer

Technology in cancer research & treatment

OncoTargets and therapy

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Luqing Zhao, Zhiting Zhao, Xiaoqi Yan, Xiao Hu, Ji-Feng Feng, Shaorong Yu
Comparison of Efficacy and Safety of Second-Line Treatment Options for Advanced Small-Cell Lung Cancer: A Retrospective Analysis. Technology in cancer research & treatment 23 (2024)
Luqing Zhao, Zhiting Zhao, Xiaoqi Yan, Xiao Hu, Ji-Feng Feng, Shaorong Yu
Comparison of Efficacy and Safety of Second-Line Treatment Options for Advanced Small-Cell Lung Cancer: A Retrospective Analysis. Technology in cancer research & treatment 23 (2024)
Dan Zou, Bowen Hu, Sitong Feng, Rujia Si, Bei Zhong, Bo Shen, Yuxin Du, Ji-Feng Feng
FN-1501 Inhibits Diffuse Large B-Cell Lymphoma Tumor Growth by Inducing Cell Cycle Arrest And Apoptosis. Anti-cancer agents in medicinal chemistry (2024)
Luqing Zhao, Zhiting Zhao, Xiaoqi Yan, Xiao Hu, Ji-Feng Feng, Shaorong Yu
Comparison of Efficacy and Safety of Second-Line Treatment Options for Advanced Small-Cell Lung Cancer: A Retrospective Analysis. Technology in cancer research & treatment 23 (2024)
Luqing Zhao, Zhiting Zhao, Xiaoqi Yan, Fei Wu, Ning Sun, Renhong Guo, Shaorong Yu, Xiao Hu, Ji-Feng Feng
Comparison of Efficacy and Safety of First-Line Treatment Options for Unresectable Stage III Non-Small Cell Lung Cancer: A Retrospective Analysis. International journal of clinical practice 2024 (2024)
Luqing Zhao, Zhiting Zhao, Xiaoqi Yan, Xiao Hu, Ji-Feng Feng, Shaorong Yu
Comparison of Efficacy and Safety of Second-Line Treatment Options for Advanced Small-Cell Lung Cancer: A Retrospective Analysis. Technology in cancer research & treatment 23 (2024)
Luqing Zhao, Zhiting Zhao, Xiaoqi Yan, Fei Wu, Ning Sun, Renhong Guo, Shaorong Yu, Xiao Hu, Ji-Feng Feng
Comparison of Efficacy and Safety of First-Line Treatment Options for Unresectable Stage III Non-Small Cell Lung Cancer: A Retrospective Analysis. International journal of clinical practice 2024 (2024)
Sitong Feng, Haixia Cao, Ying Sui, Ziyang Shen, Jianzhong Wu, Rong Ma, Ji-Feng Feng
CDCA4 interacts with IGF2BP1 to regulate lung adenocarcinoma proliferation via the PI3K/AKT pathway. Thoracic cancer 14 (8) (2023)
Sitong Feng, Haixia Cao, Ying Sui, Ziyang Shen, Jianzhong Wu, Rong Ma, Ji-Feng Feng
CDCA4 interacts with IGF2BP1 to regulate lung adenocarcinoma proliferation via the PI3K/AKT pathway. Thoracic cancer (2023)
Sitong Feng, Haixia Cao, Ying Sui, Ziyang Shen, Jianzhong Wu, Rong Ma, Ji-Feng Feng
CDCA4 interacts with IGF2BP1 to regulate lung adenocarcinoma proliferation via the PI3K/AKT pathway. Thoracic cancer 14 (8) (2023)
Sitong Feng, Haixia Cao, Ying Sui, Ziyang Shen, Jianzhong Wu, Rong Ma, Ji-Feng Feng
CDCA4 interacts with IGF2BP1 to regulate lung adenocarcinoma proliferation via the PI3K/AKT pathway. Thoracic cancer 14 (8) (2023)
Ziyang Shen, Ya Lu, Ying Sui, Sitong Feng, Ji-Feng Feng, Jinrong Zhou
Therapeutic Strategies for Resectable Stage-IIIA N2 Non-Small Cell Lung Cancer Patients: A Network Meta-Analysis. Clinical Medicine Insights. Oncology 16 (2022)
Ji-Feng Feng, Dihong Tang, Jing Wang, Qi Zhou, Jin Peng, Hanmei Lou, Yuping Sun, Yunlang Cai, Hongmin Chen, Junqin Yang, Pan Liu, Linna Wang, Jianjun Zou
SHR-1701, a bifunctional fusion protein targeting PD-L1 and TGF-β, for recurrent or metastatic cervical cancer: a clinical expansion cohort of phase 1 study. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Dongfang Dai, Hongping Zhou, Li Yin, Fei Ye, Xiao Yuan, Tao You, Xiaohui Zhao, Weiguo Long, Deqiang Wang, Xia He, Ji-Feng Feng, Deyu Chen
PELI1 promotes radiotherapy sensitivity by inhibiting noncanonical NF-κB in esophageal squamous cancer. Molecular oncology (2021)
Hui Zhang, Chenxin Xu, Chen Shi, Junying Zhang, Ting Qian, Zhuo Wang, Rong Ma, Jianzhong Wu, Feng Jiang, Ji-Feng Feng
Hypermethylation of heparanase 2 promotes colorectal cancer proliferation and is associated with poor prognosis. Journal of translational medicine 19 (1) (2021)
Zhu Wenbo, Zhao Qing, Wang Li, Zhu Hangju, Zhang Junying, Han Jing, Qing Rong, Ji-Feng Feng, Meiqi Shi
Improving the Lung Cancer Clinical Trial Development by Incorporating Competing Risk Factors. BioMed research international 2021 (2021)
Chenxin Xu, Haixia Cao, Ying Sui, Hui Zhang, Chen Shi, Jianzhong Wu, Rong Ma, Ji-Feng Feng
CDCA4 suppresses epithelial-mesenchymal transtion (EMT) and metastasis in Non-small cell lung cancer through modulating autophagy. Cancer cell international 21 (1) (2021)
Yan Lv, Xiao Ma, Yuxin Du, Ji-Feng Feng
Understanding Patterns of Brain Metastasis in Triple-Negative Breast Cancer and Exploring Potential Therapeutic Targets. OncoTargets and therapy 14 (2021)
Rong Ma, Qing Yang, Shengya Cao, Siwen Liu, Haixia Cao, Heng Xu, Jianzhong Wu, Ji-Feng Feng
Serum Platelet-Derived Growth Factor Is Significantly Lower in Patients with Lung Cancer and Continued to Decrease After Platinum-Based Chemotherapy. OncoTargets and therapy 13 (2020)
Li Yin, Jie Chen, Chengxian Ma, Shuai Pei, Mingyu Du, Yufeng Zhang, Yong Feng, Rong Yin, Xiuhua Bian, Xia He, Ji-Feng Feng
Hsa_circ_0046263 functions as a ceRNA to promote nasopharyngeal carcinoma progression by upregulating IGFBP3. Cell death & disease 11 (7) (2020)
Ya Lu, Huanhuan Sha, Xun Sun, Yuan Zhang, Yang Wu, Junying Zhang, Hui Zhang, Jianzhong Wu, Ji-Feng Feng
CRNDE: an oncogenic long non-coding RNA in cancers. Cancer cell international 20 (2020)
Hui Zhang, Shuchen Dong, Ji-Feng Feng
Epigenetic profiling and mRNA expression reveal candidate genes as biomarkers for colorectal cancer. Journal of cellular biochemistry 120 (6) (2019)
Hui Zhang, Zhuo Wang, Jianzhong Wu, Rong Ma, Ji-Feng Feng
Long noncoding RNAs predict the survival of patients with colorectal cancer as revealed by constructing an endogenous RNA network using bioinformation analysis. Cancer medicine 8 (3) (2019)
Yang Yang, Liang Hu, Chaoyu Wang, Xing Yang, Ling Song, Chunyi Jiang, Yan Li, Tianxi Li, Wen-Tao Liu, Ji-Feng Feng
p38/TF/HIF-α Signaling Pathway Participates in the Progression of CIPN in Mice. BioMed research international 2019 (2019)
Chenxin Xu, Haixia Cao, Chen Shi, Ji-Feng Feng
The Role Of Circulating Tumor DNA In Therapeutic Resistance. OncoTargets and therapy 12 (2019)
Hui Zhang, Yuanyuan Du, Zhuo Wang, Rui Lou, Jianzhong Wu, Ji-Feng Feng
Integrated Analysis of Oncogenic Networks in Colorectal Cancer Identifies GUCA2A as a Molecular Marker. Biochemistry research international 2019 (2019)
Jie Ni, Lei-Lei Zhou, Li Ding, Xue-Qin Zhang, Xia Zhao, Huizi Li, Haixia Cao, Siwen Liu, Zhuo Wang, Rong Ma, Jianzhong Wu, Ji-Feng Feng
Efatutazone and T0901317 exert synergistically therapeutic effects in acquired gefitinib-resistant lung adenocarcinoma cells. Cancer medicine 7 (5) (2018)
Lei-Lei Zhou, Xiao-Yue Xu, Jie Ni, Xia Zhao, Jian-Wei Zhou, Ji-Feng Feng
T-cell lymphomas associated gene expression signature: Bioinformatics analysis based on gene expression Omnibus. European journal of haematology 100 (6) (2018)
Xiaoyue Xu, Shaorong Yu, Wenbo Sun, Xiaobing Qin, Yan Chen, Leilei Zhou, Rui Lou, Shuchen Dong, Bo Shen, Jianzhong Wu, Jialan Zang, Haixia Cao, Meiqi Shi, Qin Zhang, Ji-Feng Feng
MiRNA signature predicts the response of patients with advanced lung adenocarcinoma to platinum-based treatment. Journal of cancer research and clinical oncology 144 (3) (2017)